Atlas Trials

Combining Varenicline and Naltrexone for Smoking Cessation

Clinical trial NCT02698215 · COMPLETED

Trial details

NCT number
NCT02698215
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nicotine DependenceAlcohol Use Disorder
Start date
2016-05-01
Primary completion
2019-12-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.